Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use

StatusNot Yet Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Minor Start date: Oct 21, 2026 to Oct 22, 2026
  2. Minor Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Many different research projects need a steady supply of human blood. Blood donated by screened, healthy people may be used to test new drugs, for example, or to learn how blood cells work. Scientists from the National Institutes of Health and the Food and Drug Administration want to collect blood from donors for use in laboratory studies. Objective: To collect blood and blood parts from healthy donors for research. Eligibility: Healthy people aged 18 years and older who weigh more than 110 pounds. They must meet the requirements to donate blood for research. Participants will be screened. A nurse will check their general health. The veins in both arms will be checked to make sure they are good for donation. Participants may donate whole blood as often as they wish, but no more than 2 cups will be taken over an 8-week period. At each visit, they will fill out a questionnaire about their health, and a small sample of blood will be tested to make sure it is safe to donate. Participants may also opt to donate only white blood cells. They will undergo leukapheresis: Blood will be taken from the body through a needle inserted into a vein. The blood will pass through a machine that separates out the white blood cells. The remaining blood will be returned to the body through a different needle. Those who donate white blood cells called granulocytes may need to take 2 drugs, including a steroid, the day before. Participants who repeat this donation will need an eye exam. Participants may remain in the study for 20 years.
Trial Details
NCT Number NCT07877259
Lead Sponsor National Institutes of Health Clinical Center (CC)
Conditions
(from sponsor)
Blood Donors, Apheresis
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov